35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid
- PMID: 53111
- DOI: 10.1111/j.1365-2265.1975.tb01930.x
35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid
Abstract
35S-methimazole (MMI), 35S-carbimazole or 35S-propylthiouracil (PTU) were given orally to fifty-five patients at various times up to 12 h before surgical thyroidectomy. The amount of 35S radioactivity and labelled drug in thyroid and plasma samples was measured. Intrathyroidal inhibition or organic binding of iodine by MMI, carbimazole and PTU was measured after intravenous administration of 131I, 132I or 125I-iodide. After administration of 35S-carbimazole or 35S-MMI the thyroid to serum (T/S) ratio of 35S radioactivity was greater in thyrotoxic glands than in non-toxic adenoma tissue. 35S-MMI was found in thyroid and plasma samples after administration of 35S-carbimazole. The T/S 35S-MMI was greater than 1 in most but not all patients. 35S radioactivity was also concentrated in the thyroid after administration of 35S-PTU. In thyrotoxic glands there was an 80% inhibition of iodine organification in patients receiving MMI and 60% for those receiving PTU. It is suggested that carbimazole and MMI can be given once or twice daily in some patients but PTU would be less suitable for this dose schedule.
Similar articles
-
The placental transfer of propylthiouracil, methimazole and carbimazole.J Clin Endocrinol Metab. 1977 Dec;45(6):1187-93. doi: 10.1210/jcem-45-6-1187. J Clin Endocrinol Metab. 1977. PMID: 591614
-
Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.Endocrinology. 1978 Dec;103(6):2187-97. doi: 10.1210/endo-103-6-2187. Endocrinology. 1978. PMID: 748042
-
The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid.Clin Sci. 1973 Jun;44(6):24P. doi: 10.1042/cs044024p. Clin Sci. 1973. PMID: 4123392 No abstract available.
-
[Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].Rinsho Byori. 1982 Feb;30(2):170-8. Rinsho Byori. 1982. PMID: 6177885 Review. Japanese. No abstract available.
-
SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.Endocr Pract. 2020 Feb;26(2):207-217. doi: 10.4158/EP-2019-0221. Epub 2019 Oct 25. Endocr Pract. 2020. PMID: 31652102
Cited by
-
Single daily dose methimazole treatment of hyperthyroidism.West J Med. 1980 Jan;132(1):13-5. West J Med. 1980. PMID: 7376643 Free PMC article.
-
Pharmacokinetics of antithyroid drugs.Klin Wochenschr. 1982 Jun 1;60(11):531-9. doi: 10.1007/BF01724208. Klin Wochenschr. 1982. PMID: 6180218 Review. No abstract available.
-
Initial treatment of thyrotoxic Graves' disease with methimazole: a randomized trial comparing different dosages.J Endocrinol Invest. 1987 Jun;10(3):291-5. doi: 10.1007/BF03348132. J Endocrinol Invest. 1987. PMID: 3305681 Clinical Trial.
-
Clinical pharmacokinetics of antithyroid drugs.Clin Pharmacokinet. 1981 Nov-Dec;6(6):401-28. doi: 10.2165/00003088-198106060-00001. Clin Pharmacokinet. 1981. PMID: 6172233 Review.
-
Correlation between antithyroid effect and serum concentrations of propylthiouracil in patients with hyperthyroidism.Br J Clin Pharmacol. 1981 Nov;12(5):681-6. doi: 10.1111/j.1365-2125.1981.tb01289.x. Br J Clin Pharmacol. 1981. PMID: 7332734 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources